Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

SOLENO THERAPEUTICS INC (SLNO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Dec-31-22Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Revenues  0.00.00.00.00.00.010.110.1
            Revenue growth    -100.0%-100.0%-100.0%-100.0%  
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.00.00.00.00.00.010.110.1
            Gross margin        100.0%100.0%
Selling, general and administrative   [+]28.927.124.421.823.819.516.716.0
Other operating expenses  -1.0-0.8-0.6-0.6-0.6-0.59.810.0
EBITDA   [+]-26.0-24.3-21.8-19.2-21.3-22.7-27.1-32.2
            EBITDA margin        -267.5%-317.0%
Depreciation and amortization  2.02.02.02.02.02.02.02.0
EBIT   [+]-28.0-26.3-23.8-21.2-23.3-24.7-29.1-34.1
            EBIT margin        -286.8%-336.4%
Other income (expense), net   [+]-0.5-0.4-0.3-0.2-0.10.00.25.4
Pre-tax income  -28.4-26.7-24.1-21.4-23.4-27.7-30.9-30.9
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -28.4-26.7-24.1-21.4-23.4-27.7-30.9-30.9
            Net margin        -304.7%-305.0%
   
Basic EPS   [+]($3.13)($3.03)($3.09)($3.05)($3.70)($1.16)($0.73)($0.54)
Diluted EPS   [+]($3.13)($3.03)($3.09)($3.05)($3.70)($1.16)($0.73)($0.54)
   
Shares outstanding (basic)   [+]9.18.87.87.06.323.942.556.8
Shares outstanding (diluted)   [+]9.18.87.87.06.323.942.556.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy